Skip to main content
Log in

Absorption of intramuscularly administered [14C]haloperidol decanoate in rats

  • Original Papers
  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

When [14C]haloperidol decanoate, an ester of haloperidol and decanoic acid, was given intramuscularly to rats, levels of total radioactivity and haloperidol decanoate in medial iliac and hypogastric sacral lymph nodes nearest to injection sites were the highest in examined lymph nodes and plasma. These lymph node levels became maximum 16 days after administration and declined gradually with half-life (around 14 days) similar to those of plasma total radioactivity, haloperidol decanote and haloperidol. However, when the labelled ester was given intravenously, plasma total radioactivity disappeared far more rapidly. Much more radioactivity was found in hind limbs whose femoral muscles had been injected than in other body parts, even at late stages after administration. Haloperidol alone was found in the brain after [14C]haloperidol decanoate was given either intramuscularly or intravenously. It was concluded that haloperidol decanoate injected in rat femoral muscle was rate-limitedly distributed in lymph circulation and that the absorbed ester did not penetrate the brain through the blood-brain barrier but formed haloperidol did.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Deberdt R., Elens P., Berghmans W., Heykants J., Woestenborghs R., Driesens F., Reyntjens A. and van Wijngaarden I. (1980): Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study. Acta Psychiat Scand.,62, 356–363.

    Article  CAS  PubMed  Google Scholar 

  2. Ayd F.J. (1980): Haloperidol decanoate: The latest depot neuroleptic. Int. Drug Ther. Newsl.,15, 5–7.

    Google Scholar 

  3. Yale H.L. (1978): The long-acting neuroleptics: A retrospective appraisal. Drug Metab. Rev.,8, 251–262.

    Article  CAS  PubMed  Google Scholar 

  4. Jann W.M., Ereshefsky L. and Saklad R.S. (1985): Clinical pharmacokinetics of the depot antipsychotics. Clin. Pharmacokinet.,10, 315–333.

    Article  CAS  PubMed  Google Scholar 

  5. Matsunaga Y., Oh-e Y., Nambu K., Kagemoto A., Negoro T., Sekine Y. and Miyazaki H. (1985): Distribution of intramuscularly administered [14C]haloperidol decanoate in rats. Jpn. Pharmacol. Ther. (in Japanese),13, 6617–6628.

    CAS  Google Scholar 

  6. Hashimoto M., Miyazaki H., Fujii T., Nambu K. and Tanaka K. (1979): Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. 1. Absorption, distribution and excretion of [14C]-tolmetine radioactivity. Drug Metab. Dispos.,7, 14–19.

    CAS  PubMed  Google Scholar 

  7. Miyazaki H., Matsunaga Y., Nambu K., Oh-e Y., Yoshida K. and Hashimoto M. (1986): Disposition and metabolism of [14C]haloperidol in rats. Arzneimittel Forsch.,36, 443–452.

    CAS  Google Scholar 

  8. Matsunaga Y., Nambu K., Oh-e Y., Miyazaki H. and Hashimoto M. (1986): Excretion and metabolism of intramuscularly administered [14C] haloperidol decanoate in rats. Arzneimittel Forsch.,36, 453–456.

    CAS  Google Scholar 

  9. Dreyfuss J., Shaw M.J. and Ross J.J. (1976): Fluphenazine enanthate and fluphenazine decanoate: Intramuscular injection and esterification as requirements for slowrelease characteristics in dogs. J. Pharm. Sei.,65, 1310–1315.

    Article  CAS  Google Scholar 

  10. Oh-e Y., Miyazaki H., Matsunaga Y., Nambu K., Kobayashi N. and Hashimoto M. (1987): Hydrolysis of haloperidol decanoate in vitro by cultured cells. Eur. J. Drug Metab. Pharmacokinet., Vol., page-page in this issue.

  11. Nambu K., Miyazaki H., Nakanishi Y., Oh-e Y., Matsunaga Y. and Hashimoto M. (1987): Enzymatic hydrolysis of haloperidol decanoate and its inhibition by proteins. Biochem. Pharmacol.,36, 1715–1722.

    Article  CAS  PubMed  Google Scholar 

  12. Oka M., Karasawa T., Ochi Y., Asano K., Terauchi Y. and Kadokawa T. (1985): Differential effects of haloperidol decanoate, a long-acting neuroleptic, in behavioral and hiochemical tests. Arch. Int. Pharmacodyn. Ther.,277, 289–303.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work was done in the periods of November, 1981 –July, 1982, June, 1983 – August, 1983 and November, 1984 –February, 1985.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Matsunaga, Y., Nambu, K., Oh-E, Y. et al. Absorption of intramuscularly administered [14C]haloperidol decanoate in rats. European Journal of Drug Metabolism and Pharmacokinetics 12, 175–181 (1987). https://doi.org/10.1007/BF03189894

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189894

Key words

Navigation